Olivier Feron

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers.

J. Machiels, J. Canon, B. Sautois, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Iron oxide particles covered with hexapeptides targeted at phosphatidylserine as MR biomarkers of tumor cell death.

V. Grégoire, S. Laurent, R. Muller, 2010, Contrast media & molecular imaging.

Neuregulin signaling in the heart. Dynamic targeting of erbB4 to caveolar microdomains in cardiac myocytes.

O. Feron, C. Dessy, R. Kelly, 1999, Circulation research.

Thyroid status and postnatal changes in subsarcolemmal distribution and isoform expression of rat cardiac dihydropyridine receptors.

T. Godfraind, F. Kolář, O. Feron, 1998, Cardiovascular research.

Dynamic contrast‐enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4

O. Feron, G. Cron, C. Bouzin, 2014, NMR in biomedicine.

Radioimmunotherapy with radioactive nanoparticles: First results of dosimetry for vascularized and necrosed solid tumors.

B. Masereel, T. Borght, S. Lucas, 2007, Medical physics.